Protenus
AcquiredBaltimore, US · Founded 2014 · Delaware corporation · 222 employees on LinkedIn · 6 known investors
Bluesight (formerly Protenus) provides AI-powered software for hospital pharmacy and compliance teams, covering RFID inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring. It integrates data from wholesalers, health records, dispensing cabinets, and HR systems to support pharmacy operations and executive analytics for health systems.
Founders & leadership
Protenus was founded in 2014 by Nicholas Culbertson.
NC
Nicholas CulbertsonFounder
HT
Harry TotonisNamed on SEC filing
MK
Michele KangNamed on SEC filing
Board
RL
Investors · 6
Reported raises · per SEC filings
Form D private placements$47.7M disclosed across 8 rounds · 2014–2021
▶$15.7MraisedMay 2021 · 9 investors · Other TechnologyRule 506(b)
▶$15.7MraisedMay 2021 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sam BraschDirector
- Robert LordDirector
- Nicholas CulbertsonExecutive Officer, Director
- Jon LimDirector
- James BurgumDirector
- Offering amount
- $20M
- Amount sold
- $15.7M
- Minimum investment
- $100K
- Proceeds to insiders
- $1M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13MraisedMay 2019 · 9 investors · Other TechnologyRule 506(b)
▶$13MraisedMay 2019 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas CulbertsonExecutive Officer, Director
- Jared KesselheimDirector
- James BraschDirector
- James BurgumDirector
- Jon LimDirector
- Jon OtterstatterDirector
- Robert LordExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $13M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$11MraisedJan 2018 · 8 investors · Other TechnologyRule 506(b)
▶$11MraisedJan 2018 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas CulbertsonExecutive Officer, Director
- Robert LordExecutive Officer, Director
- Sam BraschDirector
- Jon LimDirector
- Edward MichaelDirector
- Offering amount
- $11M
- Amount sold
- $11M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$7MraisedJul 2017 · 21 investors · Other TechnologyRule 506(b)
▶$7MraisedJul 2017 · 21 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas CulbertsonExecutive Officer, Director
- Robert LordExecutive Officer, Director
- Edward MichaelDirector
- Michele KangDirector
- John SteinerDirector
- Offering amount
- $7M
- Amount sold
- $7M
- Proceeds to insiders
- $175K
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$150KraisedMar 2015 · 2 investors · Other TechnologyRule 506(b)
▶$150KraisedMar 2015 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Robert LordExecutive Officer, Director
- Nicholas CulbertsonExecutive Officer, Director
- Harry TotonisDirector
- Michele KangDirector
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$770KraisedSep 2014 · 10 investors · Other TechnologyRule 506(b)
▶$770KraisedSep 2014 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas CulbertsonExecutive Officer, Director
- Robert LordExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $770K
- Minimum investment
- $10K
- Proceeds to insiders
- $120K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$30KraisedMay 2014 · 1 investors · Other TechnologyRule 506(b)
▶$30KraisedMay 2014 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Robert LordDirector
- Nicholas CulbertsonDirector
- Offering amount
- $30K
- Amount sold
- $30K
- Proceeds to insiders
- $12K
- First sale
- Apr 2014
- Incorporated
- Limited Liability Company, Maryland, 2014
- Federal exemptions
- 06b
▶$50KraisedMay 2014 · 3 investors · Other TechnologyRule 506(b)
▶$50KraisedMay 2014 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Robert LordDirector
- Nicholas CulbertsonDirector
- Offering amount
- $50K
- Amount sold
- $50K
- Proceeds to insiders
- $12K
- First sale
- Apr 2014
- Incorporated
- Limited Liability Company, Maryland, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Bswift4 shared keywordsbswift is an AI-native benefits administration platform that helps employers manage enrollment, eligibility, and compliance, offering both fully customizable (Unlimited) and pre-defined (Simplify) implementation paths. It also provides COBRA and compliance administration, dependent verification, payroll reconciliation, a 24/7 employee service center, and data-driven engagement tools for enterprises, mid-market employers, brokers, and channel partners.
Perkville3 shared keywordsPerkville provides a branded loyalty and referral software platform that enables businesses to drive customer engagement through points-based rewards, referral programs, promotional campaigns, and tiered membership structures.
Companies competing with Protenus for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Protenus do?
- Bluesight (formerly Protenus) provides AI-powered software for hospital pharmacy and compliance teams, covering RFID inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring. It integrates data from wholesalers, health records, dispensing cabinets, and HR systems to support pharmacy operations and executive analytics for health systems.
- Who founded Protenus?
- Protenus was founded by Nicholas Culbertson in 2014.
- Who are Protenus's investors?
- Protenus's investors include F-Prime Capital, Kaiser Permanente Ventures, Kube VC, LionBird, TCP Venture Capital, TRANSFORMATION CAPITAL.
- How much funding has Protenus raised?
- Protenus has disclosed $47.7M raised across 8 rounds.
- Where is Protenus headquartered?
- Protenus is headquartered in Baltimore, US.